Andrea de Kauwe

Andrea de Kauwe

Auto-generated profile, based on publicly available information

Andrea de Kauwe

Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2009 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AKAndrea L. de Kauwe
Andrea L. de Kauwe
ZCZhenjun Chen
Zhenjun Chen
RARobert P. Anderson
Robert P. Anderson
CKCatherine L. Keech
Catherine L. Keech
JPJason D. Price
Jason D. Price
JMJames McCluskey
James McCluskey
Celiac disease is a chronic inflammatory enteropathy caused by cellular immunity to dietary gluten. More than 90% of patients carry HLA-DQ2 encoded by HLA-DQA1*05 and DQB1*02, and gluten-specific CD4+ T cells from intestinal biopsies of these patients are HLA-DQ2-restricted, produce Th1 cytokines and preferentially recognize gluten peptides deamidated by tissue transglutaminase. We generated mice lacking murine MHC class II genes that are transgenic for human CD4 and the autoimmunity and celiac disease-associated HLA-DR3-DQ2 haplotype. Immunization with the α-gliadin 17-mer that incorporates the overlapping DQ2-α-I and DQ2-α-II epitopes immunodominant in human celiac disease generates peptide-specific HLA-DQ2-restricted CD4+ T cells. When exposed to dietary gluten, naive or gliadin-primed mice do not develop pathology. Coincident introduction of dietary gluten and intestinal inflammation resulted in low-penetrance enteropathy and tissue transglutaminase-specific IgA. Two further strains of transgenic mice expressing HLA-DR3-DQ2 and human CD4, one with a NOD background and another TCR transgenic having over 90% of CD4+ T cells specific for the DQ2-α-II epitope with a Th1 phenotype, were also healthy when consuming gluten. These humanized mouse models indicate that gluten ingestion can be tolerated without intestinal pathology even when HLA-DQ2-restricted CD4+ T cell immunity to gluten is established, thereby implicating additional factors in controlling the penetrance of celiac disease.

15 September 2005 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
AWAndrew I Webb
Andrew I Webb
Michelle DunstoneMichelle Dunstone
Michelle Dunstone
NWNicholas Williamson
Nicholas Williamson
JPJason D. Price
Jason D. Price
AKAndrea de Kauwe
Andrea de Kauwe
Anthony PurcellAnthony Purcell
Anthony Purcell
A major hurdle in designing successful epitope-based vaccines resides in the delivery, stability, and immunogenicity of the peptide immunogen. The short-lived nature of unmodified peptide-based vaccines in vivo limits their therapeutic application in the immunotherapy of cancers and chronic viral infections as well as their use in generating prophylactic immunity. The incorporation of β-amino acids into peptides decreases proteolysis, yet its potential application in the rational design of T cell mimotopes is poorly understood. To address this, we have replaced each residue of the SIINFEKL epitope individually with the corresponding β-amino acid and examined the resultant efficacy of these mimotopes. Some analogs displayed similar MHC binding and superior protease stability compared with the native epitope. Importantly, these analogs were able to generate cross-reactive CTLs in vivo that were capable of lysing tumor cells that expressed the unmodified epitope as a surrogate tumor Ag. Structural analysis of peptides in which anchor residues were substituted with β-amino acids revealed the basis for enhanced MHC binding and retention of immunogenicity observed for these analogs and paves the way for future vaccine design using β-amino acids. We conclude that the rational incorporation of β-amino acids into T cell determinants is a powerful alternative to the traditional homologous substitution of randomly chosen naturally occurring α-amino acids, and these mimotopes may prove particularly useful for inclusion in epitope-based vaccines.

20 November 2008 in Genes & Immunity
Verified
Journal Article
Closed access
KHK Haimila
K Haimila
EEE Einarsdottir
E Einarsdottir
AKA de Kauwe
A de Kauwe
LKL L E Koskinen
L L E Koskinen
QPQ Pan-Hammarström
Q Pan-Hammarström
PSP Saavalainen
P Saavalainen

1 December 2003 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
BABrett D. Aplin
Brett D. Aplin
CKCatherine L. Keech
Catherine L. Keech
AKAndrea L. de Kauwe
Andrea L. de Kauwe
TGThomas P. Gordon
Thomas P. Gordon
DCDana Cavill
Dana Cavill
JMJames McCluskey
James McCluskey
Systemic autoimmune diseases are characterized by the production of high titer autoantibodies specific for ubiquitous nuclear self-Ags such as DNA, Sm, and La (SS-B), so the normal mechanisms of B cell tolerance to disease-associated nuclear Ags have been of great interest. Mechanisms of B cell tolerance include deletion, anergy, developmental arrest, receptor editing, and B cell differentiation to the B-1 subtype. However, recent studies in our laboratory have suggested that B cell tolerance to the nuclear autoantigen La is limited in normal mice, and tolerance may reside primarily in the T cell compartment. To test this hypothesis, we created Ig transgenic mice expressing the IgM H chain from an mAb specific for a xenogeneic epitope within human La (hLa). These mice were bred with hLa-transgenic mice that constitutively express hLa in a manner comparable to endogenous mouse La. Between 5–15% of transgenic B cells developing in the absence of hLa were specific for hLa, and these cells were neither depleted nor developmentally arrested in the presence of endogenous hLa expression. Instead, these autoreactive B cells matured normally and differentiated into Ab-forming cells, capable of secreting high titer autoantibody. Additionally, the life span of autoreactive hLa-specific B cells was not reduced, and they were phenotypically and functionally indistinguishable from naive nonautoreactive hLa-specific B cells developing in the absence of hLa. Together these data suggest a lack of intrinsic B cell tolerance involving any known mechanisms indicating that these autoreactive B cells are indifferent to their autoantigen.

21 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DYDawit A. Yohannes
Dawit A. Yohannes
TFTobias L. Freitag
Tobias L. Freitag
AKAndrea de Kauwe
Andrea de Kauwe
KKKatri Kaukinen
Katri Kaukinen
KKKalle Kurppa
Kalle Kurppa
PSPäivi Saavalainen
Päivi Saavalainen
Celiac disease (CD) patients mount an abnormal immune response to gluten. T-cell receptor (TCR) repertoires directed to some immunodominant gluten peptides have previously been described, but the global immune response to in vivo gluten exposure in CD has not been systematically investigated yet. Here, we characterized signatures associated with gluten directed immune activity and identified gluten-induced T-cell clonotypes from total blood and gut TCR repertoires in an unbiased manner using immunosequencing. CD patient total TCR repertoires showed increased overlap and substantially altered TRBV-gene usage in both blood and gut samples, and increased diversity in the gut during gluten exposure. Using differential abundance analysis, we identified gluten-induced clonotypes in each patient that were composed of a large private and an important public component. Hierarchical clustering of public clonotypes associated with dietary gluten exposure identified subsets of highly similar clonotypes, the most proliferative of which showing significant enrichment for the motif ASS[LF]R[SW][TD][DT][TE][QA][YF] in PBMC repertoires. These results show that CD-associated clonotypes can be identified and that common gluten associated immune response features can be characterized in vivo from total repertoires, with potential use in disease stratification and monitoring.

13 November 2011 in Tissue Antigens
Verified
Journal Article
Closed access
PDF file
EEE. Einarsdottir
E. Einarsdottir
LKL. L. E. Koskinen
L. L. E. Koskinen
AKA. L. de Kauwe
A. L. de Kauwe
EDE. Dukes
E. Dukes
KMK. Mustalahti
K. Mustalahti
PSP. Saavalainen
P. Saavalainen